Top 10 Pharmaceutical Companies in India

Robert Gultig

21 November 2025

Top 10 Pharmaceutical Companies in India

User avatar placeholder
Written by Robert Gultig

21 November 2025

Introduction:

The pharmaceutical industry in India has been experiencing significant growth in recent years, with a focus on research, development, and production of high-quality drugs for both domestic and international markets. According to recent data, India’s pharmaceutical industry is the third largest in terms of volume and the thirteenth largest in terms of value globally. With a strong emphasis on innovation and affordability, Indian pharmaceutical companies are making a mark on the global stage.

Top 10 Pharmaceutical Companies in India:

1. Sun Pharmaceutical Industries Ltd.
– Market share: 8.1%
– Sun Pharmaceutical Industries Ltd. is the largest pharmaceutical company in India, with a strong presence in both domestic and international markets. Known for its focus on research and development, the company has a diverse portfolio of products across various therapeutic categories.

2. Dr. Reddy’s Laboratories Ltd.
– Market share: 5.6%
– Dr. Reddy’s Laboratories Ltd. is a leading Indian pharmaceutical company known for its focus on complex generics, biosimilars, and innovative research. With a strong presence in markets around the world, the company continues to expand its product offerings and reach.

3. Cipla Ltd.
– Market share: 3.9%
– Cipla Ltd. is a renowned Indian pharmaceutical company with a strong focus on respiratory, antiretroviral, and anti-infective products. The company has a significant presence in emerging markets and is known for its affordable and high-quality medications.

4. Lupin Ltd.
– Market share: 3.5%
– Lupin Ltd. is a leading pharmaceutical company in India with a strong focus on research and development. The company has a diverse portfolio of products, including branded and generic medications, and has a growing presence in markets around the world.

5. Aurobindo Pharma Ltd.
– Market share: 3.2%
– Aurobindo Pharma Ltd. is a fast-growing Indian pharmaceutical company with a focus on generic medications and active pharmaceutical ingredients. The company has a strong presence in markets across Asia, Africa, and Europe, and continues to expand its product offerings.

6. Glenmark Pharmaceuticals Ltd.
– Market share: 2.9%
– Glenmark Pharmaceuticals Ltd. is a leading Indian pharmaceutical company with a strong focus on innovative research and development. The company has a diverse portfolio of products across various therapeutic categories and is known for its high-quality and affordable medications.

7. Torrent Pharmaceuticals Ltd.
– Market share: 2.6%
– Torrent Pharmaceuticals Ltd. is a well-established Indian pharmaceutical company with a focus on specialty and generic medications. The company has a strong presence in domestic and international markets and continues to innovate and expand its product offerings.

8. Cadila Healthcare Ltd.
– Market share: 2.3%
– Cadila Healthcare Ltd. is a leading Indian pharmaceutical company with a strong focus on research and development. The company has a diverse portfolio of products, including branded and generic medications, and has a growing presence in markets around the world.

9. Biocon Ltd.
– Market share: 2.0%
– Biocon Ltd. is a renowned Indian biopharmaceutical company with a focus on research and development of novel biologics and biosimilars. The company has a strong presence in markets around the world and continues to expand its product offerings and reach.

10. Divi’s Laboratories Ltd.
– Market share: 1.7%
– Divi’s Laboratories Ltd. is a leading Indian pharmaceutical company with a focus on active pharmaceutical ingredients and custom synthesis. The company has a strong presence in markets around the world and is known for its high-quality and reliable products.

Insights:

The pharmaceutical industry in India is poised for continued growth and innovation, driven by factors such as increasing healthcare spending, rising demand for generic medications, and a focus on research and development. With a strong emphasis on quality and affordability, Indian pharmaceutical companies are well-positioned to capture a larger share of the global market. According to industry experts, the Indian pharmaceutical industry is expected to grow at a CAGR of 11% over the next five years, reaching a market size of $65 billion by 2025. As Indian companies continue to expand their product offerings and reach new markets, they are likely to play an increasingly important role in the global pharmaceutical landscape.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →